CD4+ T cell-mediated HER-2/neu-specific
β
Jan Alvar Lindencrona; Susanne Preiss; Thomas Kammertoens; Thomas SchΓΌler; Marie
π
Article
π
2003
π
John Wiley and Sons
π
French
β 134 KB
## Abstract HERβ2/neu (HERβ2) is a cell surface protoβoncogene that is often overexpressed in carcinomas. Passive administration of antiβHERβ2 antibodies in breast cancer patients has achieved promising results, but less is known about the role of antibodies in active immunization. We asked whether